Search results for “OPIATE ANTAGONISTS” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 410 patents, we discovered top 82 key players by total patent application. Euro-Celtique SA, Purdue Pharma LP, Nektar Therapeutics are dominant in this area. They take 26.10% of the total patent filing.
Euro-Celtique SA
Luxembourg, Luxembourg
Patent: 58
Purdue Pharma LP
Connecticut, United States
Patent: 27
Nektar Therapeutics
California, United States
Patent: 22
C.H. Boehringer Sohn AG & Co. KG
Rheinland-Pfalz, Germany
Patent: 20
Progenics Pharmaceuticals, Inc.
New York, United States
Patent: 17
Eli Lilly & Co.
Indiana, United States
Patent: 16
Adolor Corp.
Pennsylvania, United States
Patent: 12
Contral Clinics Oy
Finland
Patent: 11
Boehringer Ingelheim KG
Germany
Patent: 10
Orexo AB
Sweden
Patent: 9
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 58 patents applied in the last 5 years. We discover 26 most active companies in this area. The fast-growing Orexo AB, Purdue Pharma LP, Adapt Pharma Operations Ltd. take 32.76% of patent filing during this period.
Orexo AB
Sweden
Patent: 9
Purdue Pharma LP
Connecticut, United States
Patent: 6
Adapt Pharma Operations Ltd.
DUBLIN, Ireland
Patent: 4
Opiant Pharmaceuticals, Inc.
California, United States
Patent: 4
Yissum Research Development Co. Ltd.
Israel
Patent: 3
Mundipharma Pty Ltd.
Australia
Patent: 2
Emergent Product Development Gaithersburg, Inc.
United States
Patent: 2
Masimo Corp.
California, United States
Patent: 2
Theravance Biopharma R&D IP LLC
California, United States
Patent: 2
Delpor, Inc.
California, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 58 patents in last 5 years, we discover 18 new entrants. Orexo AB, Adapt Pharma Operations Ltd., Opiant Pharmaceuticals, Inc. are the most active new entrants in this area.
Orexo AB
Sweden
Patent: 9
Adapt Pharma Operations Ltd.
DUBLIN, Ireland
Patent: 4
Opiant Pharmaceuticals, Inc.
California, United States
Patent: 4
Yissum Research Development Co. Ltd.
Israel
Patent: 3
Delpor, Inc.
California, United States
Patent: 2
Consegna Pharma, Inc.
Pennsylvania, United States
Patent: 2
Mundipharma Pty Ltd.
Australia
Patent: 2
Emergent Product Development Gaithersburg, Inc.
United States
Patent: 2
Relmada Therapeutics, Inc.
New York, United States
Patent: 2
Masimo Corp.
California, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 50 patents, we discovered top 6 universities and scientific research institutions by total patent application. The University of Chicago, Yale University, Texas Tech University System are dominant in this area. They take 64.00% of the total patent filing.
The University of Chicago
Illinois, United States
Patent: 18
Yale University
Connecticut, United States
Patent: 10
Texas Tech University System
Texas, United States
Patent: 2
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 2
Louisiana State University
Louisiana, United States
Patent: 1
University of Miami
United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: